老虎证券

BRIEF-SCIENTURE And BlinkRx Announce Strategic Collaboration To Expand Patient Access To Arbli, The First FDA-Approved Ready-To-Use Oral Suspension Of Losartan Potassium

Reuters
2025/12/10
BRIEF-SCIENTURE And BlinkRx Announce Strategic Collaboration To Expand <a href="https://laohu8.com/S/PASO">Patient Access</a> To Arbli, The First FDA-Approved Ready-To-Use Oral Suspension Of Losartan Potassium

Dec 10 (Reuters) - Scienture Holdings Inc SCNX.O:

  • SCIENTURE AND BLINKRX ANNOUNCE STRATEGIC COLLABORATION TO EXPAND PATIENT ACCESS TO ARBLI™, THE FIRST FDA-APPROVED READY-TO-USE ORAL SUSPENSION OF LOSARTAN POTASSIUM

  • SCIENTURE HOLDINGS INC - ARBLI EXPECTED ON BLINKRX PLATFORM IN Q1 2026

Source text: ID:nGNX8zLbfl

Further company coverage: SCNX.O

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10